News from the World of Clinical Research

Report finds almost 100% of people tested positive for antibodies after second vaccine dose

A new report from Imperial College London and Ipsos MORI has shown that almost 100% of people tested positive for antibodies 14 days after their second dose of the Pfizer/BioNTech or AstraZeneca COVID…

Biohaven CEO on migraine drug's fast launch, TikTok ads and battling big pharma

Migraine sufferers in the U.S. found some relief over the past few years as a handful of new treatments came to market. The additions include a group of injectable drugs that help prevent the painful …

‘Most comprehensive’ flu vaccination programme in UK history launching for winter 2021

The government has announced that it will launch the ‘most comprehensive’ flu vaccination programme in UK history for winter 2021.

Moving the vaccination needle: Study examines behavioral tactics that work—and don't

One of the big questions today is how to get more people vaccinated. Should you offer free stuff? That works sometimes. Remind them that they’re good parents? That actually doesn’t work.

Study finds lower COVID-19 infection prevalence in fully vaccinated people

The latest findings from Imperial College London’s REACT study show that rates of COVID-19 infection are three times lower in fully vaccinated people under the age of 65 compared to unvaccinated peopl…

Pfizer plots course for COVID-19 booster, but the CDC isn't sure 'whether or when' follow-up shots will be needed

Throughout the pandemic, mixed messaging has sometimes hindered the public's understanding of how best to respond. On boosters, that seems to be happening again.

GSK returns to brain drugs with major biotech deal

• GlaxoSmithKline said Friday it will pay at least $700 million for rights to two experimental drugs for neurodegenerative diseases, a deal that could be seen as momentous for the U.K. pharmaceutical …

U.K. Supreme Court rejects NHS claim of €220M financial loss in Servier patent lawsuit

In the culmination of a 10-year case, the U.K. Supreme Court has ruled in favor of Servier Laboratories in its defense against England’s National Health Service over a patent on cardio drug Coversyl.

Roche partner sees promise for anti-COVID 19 pill in early study

• An experimental pill under development by Atea Pharmaceuticals and Roche helped curb viral loads in hospitalized patients with coronavirus infections, according to interim results from a Phase 2 tri…

AZ doses first participants with COVID-19 variant vaccine

AstraZeneca (AZ) has announced that the first participants have been vaccinated as part of a Phase II/III trial testing a new COVID-19 variant vaccine – AZD2816.

Australia Covid: Outbreaks emerge across country in 'new phase' of pandemic

Australia's Prime Minister Scott Morrison has met national leaders for emergency talks on how to tackle a spike in Covid-19 infections.

Blood test can detect more than 50 types of cancer

Researchers have developed a blood test able detect more than 50 types of cancer that is accurate enough to be used nationally as a multi-cancer screening test in those at higher risk of the disease, …

Public Citizen calls for top FDA officials to resign following Alzheimer's drug approval

The prominent consumer advocacy group Public Citizen is calling for the resignations of three top officials at the Food and Drug Administration, following the agency's decision to approve a controvers…

Pfizer's arthritis drug Xeljanz shows lifesaving benefits in hospitalized COVID-19 patients

Pfizer’s BioNTech-partnered COVID-19 vaccine Comirnaty may be getting all the attention these days, but the pharma giant’s anti-inflammatory drug Xeljanz just chalked up a win in treating patients hos…

Trial failure dashes Biogen hopes for next Alzheimer's drug

• An experimental Alzheimer's disease treatment developed by Biogen didn't slow patients' decline when compared to a placebo in a mid-stage study, leading the Massachusetts-based biotech to halt all w…